Assistant Professor
Eric Shifrut is an Assistant Professor at Tel Aviv University and a principal investigator at Tel Aviv Sourasky Medical Center. Eric completed his graduate studies at the Weizmann Institute of Science, mapping the TCR repertoire in health and disease. For his postdoctoral training, he joined Alex Marson at UCSF to pioneer CRISPR discovery platforms to study primary human T cells. Eric has co-authored 27 papers and 6 patents in the fields of immunology and cell therapy, which have been cited over 2,500 times. Today, Eric leads an independent team with the mission to leverage these achievements in CRISPR engineering to design best-in-class T cell therapies against cancer.